Drugs

Disseminated Mycobacterium avium-intracellulare Complex (MAC) Infection in the Era of Effective Antiretroviral Therapy: Is Prophylaxis Still Indicated?
pp. 679-692(14)
Authors: Lange C.G.; Woolley I.J.; Brodt R.H.

Challenges in the Management of HIV and Hepatitis C Virus Co-infection
pp. 693-700(8)
Authors: Lee W.; Dieterich D.

Adverse Metabolic Effects Associated with Atypical Antipsychotics: Literature Review and Clinical Implications
pp. 701-723(23)
Authors: Melkersson K.; Dahl M-L.

The Anabolic Androgenic Steroid Oxandrolone in the Treatment of Wasting and Catabolic Disorders: Review of Efficacy and Safety
pp. 725-750(26)
Authors: Orr R.; Maria Fiatarone Singh

Ethinylestradiol/Chlormadinone Acetate
pp. 751-760(10)
Authors: Curran M.P.; Wagstaff A.J.

Ethinylestradiol/Chlormadinone Acetate: A Viewpoint by Hans Peter Zahradnik
pp. 761-762(2)
Author: Zahradnik H.P.

Ethinylestradiol/Chlormadinone Acetate: A Viewpoint by Ulrich Winkler
pp. 761-762(2)
Author: Winkler U.

Ethinylestradiol/Chlormadinone Acetate: A Viewpoint by Herbert Kuhl
pp. 761-762(2)
Author: Kuhl H.

Inhaled Iloprost: In Primary Pulmonary Hypertension
pp. 763-773(11)
Authors: Goldsmith D.R.; Wagstaff A.J.

Inhaled Iloprost: A Viewpoint by Nazzareno Galiè
pp. 774-775(2)
Authors: Galiè N.

Inhaled Iloprost: A Viewpoint by J. Simon R. Gibbs
pp. 774-775(2)
Author: Gibbs J.S.R.

Inhaled Iloprost: A Viewpoint by Tine L.M. De Backer
pp. 774-775(2)
Author: De Backer T.L.M.

Aprepitant: A Review of its Use in the Prevention of Chemotherapy-Induced Nausea and Vomiting
pp. 777-794(18)
Authors: Dando T.M.; Perry C.M.